MET and gastric neoplasm: In fact, gastric tumors that display MET gene amplification (10% of cases) are potentially addicted to MET expression and can be considered ideal targets for anti-MET therapies; however, aberrant activation of HER family members has also been shown to be concomitant in these tumors [36,37].